Methadone + Ketamine for Pain Management in Liver Transplant
(RELIEF-LT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a history of substance abuse or are on opioid maintenance therapies, you may not be eligible to participate.
What data supports the effectiveness of the drug combination of Methadone and Ketamine for pain management in liver transplant patients?
Research shows that combining ketamine with other pain medications like morphine can extend the duration of pain relief after surgery. Additionally, using methadone with ketamine has been found to reduce the need for other pain medications after surgery, suggesting that this combination could be effective for managing pain in liver transplant patients.12345
Is the combination of methadone and ketamine generally safe for pain management?
Research shows that combining methadone and ketamine can reduce the need for other opioids after surgery, but there may be side effects like vivid dreaming and cognitive issues. In cirrhotic patients, a small dose of ketamine with morphine was effective for pain relief without significant side effects.23467
How is the drug combination of methadone and ketamine unique for pain management in liver transplant patients?
What is the purpose of this trial?
The goal of this clinical trial is to learn if using methadone and ketamine during an adult deceased donor liver transplant can help decrease pain after surgery.The main questions it aims to answer are:* What impact does using methadone and ketamine during a deceased donor liver transplant have on pain after surgery?* Does the use of methadone and ketamine also have an impact on mental confusion (delirium) after surgery?Researchers will compare the use of methadone and ketamine to standard of care to see if the two drugs work to decrease pain and impact delirium after liver transplant.Participants will:* Receive either methadone and ketamine or standard of care during their deceased donor liver transplant.* Allow researchers to follow medical care throughout inpatient stay.
Research Team
Ryan Nazemian, MD, PhD
Principal Investigator
Lahey Hospital and Medical Center, Department of Anesthesiology, Perioperative and Pain Medicine
Eligibility Criteria
This trial is for adults undergoing a deceased donor liver transplant, aiming to reduce post-surgery pain. Participants will be observed throughout their hospital stay.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either methadone and ketamine or standard of care during their deceased donor liver transplant
Postoperative Monitoring
Participants are monitored for pain management, delirium, and respiratory complications post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Ketamine
- Methadone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lahey Clinic
Lead Sponsor